Zhejiang Xianju Pharmaceutical(002332.SZ): Dexamethasone sodium phosphate injection approved for registration.

Zhejiang Xianju Pharmaceutical (002332.SZ) announced that the company has recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for dexamethasone sodium phosphate injection. The company's dexamethasone sodium phosphate injection has been approved for registration. Dexamethasone sodium phosphate injection is mainly used for diseases that require treatment with glucocorticoids.